These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 15154938

  • 1. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
    Antoniades C, Tousoulis D, Tountas C, Tentolouris C, Toutouza M, Vasiliadou C, Tsioufis C, Toutouzas P, Stefanadis C.
    Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
    [Abstract] [Full Text] [Related]

  • 2. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
    Tentolouris C, Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Trikas A, Toutouzas P, Stefanadis C.
    Int J Cardiol; 2004 Apr; 94(2-3):301-5. PubMed ID: 15093997
    [Abstract] [Full Text] [Related]

  • 3. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H.
    J Am Coll Cardiol; 2005 May 17; 45(10):1622-30. PubMed ID: 15893178
    [Abstract] [Full Text] [Related]

  • 4. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
    Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, Ladis V, Karageorga M, Pitsavos C, Stefanadis C.
    Int J Cardiol; 2005 Oct 20; 105(1):80-4. PubMed ID: 16207549
    [Abstract] [Full Text] [Related]

  • 5. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone.
    Martens FM, Rabelink TJ, op 't Roodt J, de Koning EJ, Visseren FL.
    Eur Heart J; 2006 Jul 20; 27(13):1605-9. PubMed ID: 16762982
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher AM.
    J Am Coll Cardiol; 2004 Jul 07; 44(1):44-9. PubMed ID: 15234404
    [Abstract] [Full Text] [Related]

  • 7. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
    Nyström T, Nygren A, Sjöholm A.
    Clin Sci (Lond); 2006 Jun 07; 110(6):673-81. PubMed ID: 16466346
    [Abstract] [Full Text] [Related]

  • 8. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.
    Metabolism; 2003 Feb 07; 52(2):173-80. PubMed ID: 12601628
    [Abstract] [Full Text] [Related]

  • 9. Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction.
    Nyström T, Nygren A, Sjöholm A.
    Clin Sci (Lond); 2005 Feb 07; 108(2):121-8. PubMed ID: 15504106
    [Abstract] [Full Text] [Related]

  • 10. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar 07; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 11. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
    Shemyakin A, Kövamees O, Rafnsson A, Böhm F, Svenarud P, Settergren M, Jung C, Pernow J.
    Circulation; 2012 Dec 18; 126(25):2943-50. PubMed ID: 23183942
    [Abstract] [Full Text] [Related]

  • 12. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S, Gielen S, Linke A, Möbius-Winkler S, Adams V, Baither Y, Schuler G, Hambrecht R.
    Am Heart J; 2003 Aug 18; 146(2):280-5. PubMed ID: 12891196
    [Abstract] [Full Text] [Related]

  • 13. Vascular insulin response is preserved in non-diabetic patients with coronary artery disease, despite endothelial dysfunction.
    Ihlemann N, Rask-Madsen C, Køber L, Torp-Pedersen C.
    Scand Cardiovasc J; 2004 Mar 18; 38(1):22-7. PubMed ID: 15204243
    [Abstract] [Full Text] [Related]

  • 14. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S, Signorelli SS, Torrisi B, Pulvirenti D, Mauceri B, Abate G, Ignaccolo L, Bordonaro F, Cilio D, Calvagno S, Leotta C.
    Clin Ther; 2005 Nov 18; 27(11):1764-73. PubMed ID: 16368447
    [Abstract] [Full Text] [Related]

  • 15. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.
    Boulbou MS, Koukoulis GN, Makri ED, Petinaki EA, Gourgoulianis KI, Germenis AE.
    Int J Cardiol; 2005 Jan 18; 98(1):39-44. PubMed ID: 15676164
    [Abstract] [Full Text] [Related]

  • 16. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V.
    Diabetologia; 2002 Mar 18; 45(3):420-6. PubMed ID: 11914748
    [Abstract] [Full Text] [Related]

  • 17. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
    Antoniades C, Tousoulis D, Marinou K, Papageorgiou N, Bosinakou E, Tsioufis C, Stefanadi E, Latsios G, Tentolouris C, Siasos G, Stefanadis C.
    Clin Cardiol; 2007 Jun 18; 30(6):295-300. PubMed ID: 17551966
    [Abstract] [Full Text] [Related]

  • 18. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI, Sheu WH, Song YM, Liu HC, Lee WJ, Chen YT.
    Diabet Med; 2004 Apr 18; 21(4):336-41. PubMed ID: 15049935
    [Abstract] [Full Text] [Related]

  • 19. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
    Mohan V, Deepa R, Velmurugan K, Premalatha G.
    Diabet Med; 2005 Jul 18; 22(7):863-70. PubMed ID: 15975100
    [Abstract] [Full Text] [Related]

  • 20. Endothelial dysfunction in type 2 diabetic patients with normal coronary arteries: a digital reactive hyperemia study.
    Gargiulo P, Marciano C, Savarese G, D'Amore C, Paolillo S, Esposito G, Santomauro M, Marsico F, Ruggiero D, Scala O, Marzano A, Cecere M, Casaretti L, Perrone Filardi P.
    Int J Cardiol; 2013 Apr 30; 165(1):67-71. PubMed ID: 21851998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.